Antitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivo.
Usui, N
Antitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivo. [electronic resource] - Biotherapy (Dordrecht, Netherlands) 1996 - 199-208 p. digital
Publication Type: Journal Article
0921-299X
10.1007/BF02620733 doi
Animals
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Drug Synergism
Etoposide--administration & dosage
Female
Humans
Interleukin 1 Receptor Antagonist Protein
Interleukin-1--administration & dosage
Mice
Mice, Inbred BALB C
Neoplasms, Experimental--drug therapy
Recombinant Proteins--administration & dosage
Sialoglycoproteins--pharmacology
Superoxide Dismutase--metabolism
Superoxides--metabolism
Tumor Cells, Cultured
Antitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivo. [electronic resource] - Biotherapy (Dordrecht, Netherlands) 1996 - 199-208 p. digital
Publication Type: Journal Article
0921-299X
10.1007/BF02620733 doi
Animals
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Drug Synergism
Etoposide--administration & dosage
Female
Humans
Interleukin 1 Receptor Antagonist Protein
Interleukin-1--administration & dosage
Mice
Mice, Inbred BALB C
Neoplasms, Experimental--drug therapy
Recombinant Proteins--administration & dosage
Sialoglycoproteins--pharmacology
Superoxide Dismutase--metabolism
Superoxides--metabolism
Tumor Cells, Cultured